Article révisé par les pairs
Résumé : Background & Aims: A more complete understanding of the mechanisms involved in pathogen-associated molecular pattern signaling is crucial in the setting of liver injury. In intestinal diseases, nucleotide-binding oligomerization domain 1 (NOD1), a receptor for bacteria, appears to regulate cross-talk between innate and adaptive immunity, involving polymorphonuclear neutrophils (PMNs). Our aim was to explore the role of NOD1 in PMN-induced liver injury. Methods: Nod1+/+ and Nod1-/- mice were challenged with carbon tetrachloride (CCl4). Migration and phagocytosis of Nod1+/+ and Nod1-/- PMN were studied in vivo and ex vivo. We evaluated main inflammatory pathways in PMNs by Western blot and CD11b expression using fluorescence-activated cell sorting. Mice were submitted to liver ischemia/reperfusion. Results: After CCl4 exposure, livers of Nod1-/- mice had more than 50% less PMN infiltration within necrotic areas than those of Nod1+/+. PMNs isolated from Nod1-/- mice displayed a 90% decrease in migration capacity compared with Nod1+/+ PMNs, whereas FK 565, a potent NOD1 ligand, increased PMN migration. Upon FK 565 stimulation, mitogen-activated protein kinase and nuclear factor ?B were activated in Nod1+/+ PMNs, but less so in Nod1-/- PMNs. Expression of CD11b on the Nod1-/- PMN was decreased compared with Nod1+/+. The phagocytic capacity of Nod1-/- PMNs was decreased by more than 50% compared with Nod1+/+. In an ischemia/reperfusion model of PMN-induced liver injury, FK 565 increased lesions, whereas Nod1-/- mice were protected. Conclusions: The identification of NOD1 as a modulator of PMN function and migration in the liver suggests that this receptor may represent a new therapeutic target in PMN-dependent liver diseases. ? 2010 AGA Institute.

Documents en relation

DI-fusion